Wednesday 21 August 2013

Often Expand Your Desires . India's No. 1 Social Networking Site

http://health-articles.info/profollica-review-hair-loss-regrowth
Often Expand Your Desires . India's No. 1 Social Networking Site
Profollica promises to stop baldness and it includes the possibility to regrow lost hair using a three component strategy. Regular hair fall is roughly 50 to 100 hairs each day but a receding hair line or thinning crown is actually a cause for concern. Hair loss may be due to poor food regime, stress, illness, drugs or other factors, but the most typical cause is genetics.

According to the American Hair Loss Association, male pattern baldness (MPB) accounts for more than 95% of male hair loss and 25% of men with MPB begin losing their hair before the age of 21. Scientific studies for more than 15 years established that MPB is caused by genetic sensitivity to dihydrotestosterone (DHT), which is really a powerful kind of testosterone. DHT initiates follicle miniaturization as it causes hair follicles to get brittle, progressively thinned and becoming smaller until these cease growing and the follicles die.

Options available to treat hair loss include prescription drugs, namely Finasteride and Minoxidil. While Minoxidil doesn't address the hormonal DHT issue, Finasteride, which is advertised as Propecia, has shown good overall results but these come with debilitating longterm sexual side effects.

In a safety investigation of Propecia conducted by the Swedish Medical Products Agency last December 2008, it was advised that the drugs may result in irreversible sexual dysfunction and noted that erection problems continue indefinitely despite discontinuing its use.

"Traditional choices for hair loss include drugs and surgery, but both have important drawbacks. The Profollica system has none of these drawbacks. It uses allnatural ingredients which were carefully selected for safety and efficacy," connected Dr. KarenVieira, Ph.D in Biomedical Sciences, MS in Management and proprietor of The Med Writers.

No comments:

Post a Comment